Safety and Blood Level Study of Unit Dose Budesonide

NCT00627679 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Budesonide Inhalation Suspension
DRUG: MAP0010 low dose
DRUG: MAP0010 intermediate dose
DRUG: MAP0010 high dose

Sponsor

Allergan

Collaborators

[object Object]
[object Object]